Medical Eligibility for GLP-1: Who Can Use It

Published January 11, 2026 | Medical Guide | 7 min read

Not everyone should use Semaglutide or Tirzepatide. This guide covers who is eligible, medical screening required, and contraindications.

Basic Eligibility Requirements

YES - Good Candidates:

  • BMI > 27 with health condition (diabetes, hypertension)
  • BMI > 30 even without health conditions
  • Prior weight loss attempts failed
  • Motivated to maintain lifestyle changes
  • Age 18-75 (primary range)
  • No contraindications (see below)

NO - Not Eligible:

  • History of medullary thyroid cancer (personal or family)
  • Multiple Endocrine Neoplasia type 2 (MEN2)
  • Pregnant or planning pregnancy
  • Current pancreatitis or gallbladder disease
  • Severe kidney disease (eGFR < 15)
  • Uncontrolled diabetic retinopathy
  • Severe psychiatric conditions (need evaluation)

Medical Screening Required

Before starting GLP-1, EkoPeptide requires:

Essential Labs (Blood Tests)

EkoPeptide can refer you to accredited lab partners and help interpret results.

Vitals Assessment

Medical History Review

Conditions That Need Extra Caution

Type 2 Diabetes

GLP-1 GOOD for diabetics - actually helps. BUT: If on other diabetes drugs (metformin, sulfonylureas), dosage may need adjustment. Risk of low blood sugar. Requires doctor oversight.

High Blood Pressure

GLP-1 often IMPROVES blood pressure. But rapid weight loss + blood pressure meds = excessive lowering possible. Monitor closely. May need to reduce BP meds.

History of Eating Disorders

GLP-1 suppresses appetite. If you have history of anorexia/bulimia, appetite suppression could be triggering. Psychiatric evaluation recommended first.

Gastroparesis or Stomach Issues

GLP-1 slows gastric emptying intentionally. If you already have slow digestion, this could worsen. Usually still ok but needs monitoring.

Kidney Disease (Mild-Moderate)

GLP-1 safe in mild kidney disease (eGFR 30-60). Moderate (eGFR 15-30) requires careful monitoring. Severe (eGFR < 15) contraindicated.

Gout or High Uric Acid

Rapid weight loss can trigger gout attacks. If history of gout, discuss with doctor. May need allopurinol alongside GLP-1.

Drug Interactions to Consider

GLP-1 has few interactions but some matter:

Diabetes Medications: If on sulfonylureas (glibenclamide, glipizide), GLP-1 increases low blood sugar risk. Dose reduction usually needed.

Blood Pressure Medications: Rapid weight loss = need for dose reduction. Don't stop on your own. Doctor monitors and adjusts.

Birth Control Pills: Nausea/vomiting can reduce effectiveness. Use backup contraception first 4 weeks.

Warfarin (Blood Thinner): Weight loss affects warfarin dosing. Requires frequent INR monitoring.

Most Other Meds: No significant interactions. GLP-1 doesn't affect cytochrome P450 metabolism.

Age Considerations

Age 18-40: Excellent candidates. Metabolism fast, recovery quick, results optimal.

Age 40-60: Still excellent candidates. Results slightly slower than younger ages but very good. May have comorbidities requiring oversight.

Age 60+: GLP-1 still works. But more medical complexity. Additional monitoring needed. Kidney function particularly important to check.

Age < 18: Generally not approved. Only in exceptional pediatric obesity cases with expert supervision.

Pregnancy & Breastfeeding

Pregnant: GLP-1 is CONTRAINDICATED (forbidden). Pregnancy is 9-month condition where weight loss inappropriate. Animal studies show potential fetal impact. Stop GLP-1 if pregnancy planned or occurs.

Breastfeeding: Unknown safety. Recommended to stop GLP-1. If must continue, discuss with doctor - most recommend waiting until nursing complete.

Trying to Conceive: Stop GLP-1 ideally 3 months before conception planning. Allows metabolism to stabilize.

Surgical Considerations

If surgery planned:

Red Flags - Stop GLP-1 Immediately

Severe abdominal pain: Could indicate pancreatitis. Seek emergency care.

Signs of thyroid cancer: Lump in neck, difficulty swallowing, persistent hoarseness. Get ultrasound immediately.

Severe dehydration: Dark urine, severe dizziness, inability to drink. IV fluids may needed.

Gallbladder pain: Upper right abdomen pain with fever. May need emergency ultrasound and care.

The Screening Process at EkoPeptide

  1. Initial WhatsApp Consultation: Basic medical history, eligibility questions
  2. Lab Ordering: If eligible, we order screening labs at partner facilities
  3. Results Review: Doctor reviews labs, checks for contraindications
  4. Telemedicine Consultation: Personal doctor call, medication education, prescription
  5. Medication Delivery: Express Lagos delivery
  6. Ongoing Monitoring: Weekly check-ins first month, monthly thereafter

Next Steps

Start with a WhatsApp consultation. If appropriate, we’ll arrange baseline labs and clinician review before any medication is dispensed.

START MEDICAL SCREENING

EkoPeptide doctors assess your eligibility • Fast Lagos labs • Confidential evaluation

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.

Medically Reviewed by Dr. Chukwuemeka Okonkwo

MBBS, FMCP - Endocrinology

Content reviewed by qualified healthcare professionals for accuracy.